Overview
- IndustryWholesale-Medical, Dental & Hospital Equipment & Supplies2
- HeadquartersWilmington, United States2
- Incorporated inDE3
- Business address1565 North Central Expressway, Suite 220, Richardson, Tx 750803
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formCorporation2
- LEI5493002BLLYWXTCBFW262
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O CAPITOL SERVICES, INC., 19901 Dover, United States2
- Registered withDivision of Corporations, Department of State, 30645102
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue38¢$7.1M
- Selling, general and admin35¢$6.5M
- Other costs9¢$1.7M
- Interest1¢$171.3K
- Income tax0¢$23.7K
- Profit17¢$3.1M
Out of $18.6M in revenue.4
Where each dollar of operating cash went, fiscal 2022
- Kept or used elsewhere100¢$34.8K
Out of $34.8K of cash from operations.4
Financial statements
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | $25.7M5 | $26.4M6 | $26.3M7 | $22.9M8 | $21.4M9 | $20.4M4 | $18.6M4 |
| Cost of revenue | $11.3M5 | $14.6M6 | $13.4M7 | $11.8M8 | $8.7M9 | $8.5M4 | $7.1M4 |
| Gross profit | $14.4M5 | $11.8M6 | $13.0M7 | $11.1M8 | $12.7M9 | $11.9M4 | $11.5M4 |
| Selling, general and admin | $4.2M5 | $5.3M6 | $8.5M7 | $8.5M8 | $6.5M9 | $7.0M4 | $6.5M4 |
| Operating expenses | $14.1M4 | $12.4M4 | |||||
| Operating income | $3.2M5 | $858.9K6 | -$2.0M7 | -$4.3M8 | -$1.0M9 | -$2.2M4 | -$815.1K4 |
| Interest | $146.9K5 | $161.7K6 | $133.9K7 | $121.6K8 | $95.0K9 | $78.2K4 | $171.3K4 |
| Income before tax | -$1.6M4 | $3.1M4 | |||||
| Income tax | $51.6K5 | $40.8K6 | -$386.8K7 | $781.1K8 | $19.0K9 | $17.7K4 | $23.7K4 |
| Net income | $3.0M5 | $699.7K6 | $4.0M7 | -$3.3M8 | -$1.4M9 | -$1.6M4 | $3.1M4 |
| Earnings per share | $0.425 | $0.046 | $0.067 | -$0.058 | -$0.029 | -$0.024 | $0.044 |
| Earnings per share (diluted) | $0.335 | $0.046 | $0.057 | -$0.058 | -$0.029 | -$0.024 | $0.044 |
| Shares (weighted, basic) | 70.3M shares4 | 70.3M shares4 | |||||
| Shares (weighted, diluted) | 70.3M shares4 | 77.9M shares4 |
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash | $778.4K6 | $804.7K7 | $844.3K7 | $1.1M8 | $1.2M9 | $553.2K4 | $147.9K4 |
| Receivables | $3.5M4 | $4.0M4 | |||||
| Inventory | $8.7M4 | $9.5M4 | |||||
| Current assets | $18.7M5 | $18.0M6 | $17.2M7 | $14.2M8 | $12.6M9 | $12.8M4 | $13.8M4 |
| Property, plant and equipment | $7.3K4 | $7094 | |||||
| Goodwill | $2.0M4 | $2.0M4 | |||||
| Intangible assets | $1.3M4 | $1.2M4 | |||||
| Total assets | $19.6M5 | $19.2M6 | $22.2M7 | $18.4M8 | $17.4M9 | $18.3M4 | $19.8M4 |
| Accounts payable | $4.5M4 | $5.7M4 | |||||
| Current liabilities | $9.0M5 | $8.0M6 | $7.1M7 | $8.0M8 | $7.2M9 | $9.9M4 | $12.4M4 |
| Long-term debt | |||||||
| Total liabilities | $9.0M5 | $27.2M6 | $20.7M7 | $19.6M8 | $19.5M9 | $21.7M4 | $20.1M4 |
| Retained earnings | -$5.6M4 | -$2.5M4 | |||||
| Shareholders’ equity | $10.6M6 | -$8.0M7 | $1.5M8 | -$1.2M9 | -$2.1M4 | -$3.4M4 | -$310.9K4 |
| Shares outstanding | 15.9M shares5 | 65.9M shares6 | 74.6M shares7 | 73.1M shares8 | 73.1M shares9 | 72.9M shares4 | 73.9M shares4 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash from operations | $2.8M5 | $1.6M6 | $2.5M7 | -$4.7K8 | $236.7K9 | -$1.8M4 | $34.8K4 |
| Depreciation and amortization | $67.6K4 | $137.4K4 | |||||
| Stock-based compensation | $257.9K4 | $22.9K4 | |||||
| Capital spending | $20.3K6 | $41.8K7 | $15.3K8 | $20.8K9 | |||
| Free cash flow | $1.6M | $2.4M | -$20.1K | $215.9K | |||
| Cash from financing | $1.1M4 | -$440.1K4 |
What it owns
What Fuse Medical, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $20.2K4 Dec 31, 2022 | $20.2K4 Dec 31, 2021 | 0% |
| Accumulated depreciation | $19.5K4 Dec 31, 2022 | $13.0K4 Dec 31, 2021 | +50.3% |
| Property and equipment, net | $7094 Dec 31, 2022 | $7.3K4 Dec 31, 2021 | −90.2% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $147.9K4 Dec 31, 2022 | $553.2K4 Dec 31, 2021 | −73.3% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $2.0M4 Dec 31, 2022 | $2.0M4 Dec 31, 2021 | 0% |
| Intangible assets, net (excluding goodwill) | $1.2M4 Dec 31, 2022 | $1.3M4 Dec 31, 2021 | −9.6% |
| Accumulated amortization | $310.1K4 Dec 31, 2022 | $179.2K4 Dec 31, 2021 | +73.0% |
| Finite-lived intangibles, net | $486.6K4 Dec 31, 2022 | $613.0K9 Dec 31, 2021 | −20.6% |
Inventory
Leadership
Who has led Fuse Medical, Inc., and when. Pick a name to see everywhere that person has worked.
Chair
Chief financial officer
Chief operating officer
- Chief executive officerChristopher C. Reeg Dec 29, 2016 to Dec 16, 202212
- Chief executive officerChris Pratt Aug 31, 2015 to Dec 13, 201613
- Chief executive officerD. Alan Meeker Jun 4, 2014 to Dec 16, 201414
- ChairMark W. Brooks Feb 23, 2022 to Dec 16, 202215
- PresidentMark W. Brooks Dec 14, 2018 to Dec 16, 202216
- PresidentRobert H. Donehew Aug 16, 2013 to Feb 12, 201617
- Chief financial officerLawrence Scott Yellin May 26, 2022 to Dec 16, 202218
- Chief financial officerWilliam E. McLaughlin Iii. Dec 14, 2018 to Dec 14, 201819
- Chief financial officerDavid Hexter Jun 4, 2014 to Aug 31, 201520
- Chief operating officerRobert H. Donehew Dec 13, 2016 to Dec 13, 201621
Board members and other officers (17)
- OfficerWilliam E. McLaughlin Iii. Oct 10, 2017 to Dec 20, 201722
- OfficerMark W. Brooks Dec 29, 2016 to Dec 29, 201623
- Chief Medical OfficerChris Pratt Jun 4, 2014 to Jun 4, 201424
- Medical Director of PodiatryRandall Dei Jun 4, 2014 to Jun 4, 201425
- Chief Development OfficerRusty Shelton Jun 4, 2014 to Jun 4, 201426
- Board memberLawrence Scott Yellin May 26, 2022 to Dec 16, 202218
- Board memberRenato Bosita V. Jr. Oct 10, 2017 to Dec 21, 201827
- Board memberRicky Raj S. Kalra Oct 10, 2017 to Dec 14, 201828
- Board memberChristopher C. Reeg Dec 29, 2016 to Dec 16, 202212
- Board memberMark W. Brooks Dec 29, 2016 to Dec 14, 201823
- Board memberWilliam E. McLaughlin Iii. Dec 29, 2016 to Dec 14, 201829
- Board memberChris Pratt Jun 4, 2014 to Dec 13, 201624
- Board memberD. Alan Meeker Jun 4, 2014 to Dec 16, 201414
- Board memberDavid Hexter Jun 4, 2014 to Jun 4, 201420
- Board memberRandall Dei Jun 4, 2014 to Dec 13, 201625
- Board memberRusty Shelton Jun 4, 2014 to Dec 13, 201626
- Board memberRobert H. Donehew Aug 16, 2013 to Dec 13, 201617
Former names
Timeline
- Sep 27, 20238-K Results of operations30
- Aug 15, 20238-K Results of operations31
- Jun 26, 20238-K Shareholder vote32
- Apr 18, 20238-K Results of operations33
- Nov 22, 20228-K Change of auditor34
- Nov 18, 20228-K Results of operations35
- Jun 28, 20228-K Shareholder vote36
- Apr 8, 20228-K Executive or director change37
- Dec 20, 20218-K New debt or obligation38
- Dec 3, 20218-K Executive or director change39
- Nov 12, 20218-K Entered a material agreement40
- Dec 29, 2016New chief executive Christopher C. Reeg becomes CEO12
- Aug 31, 2015New chief executive Chris Pratt becomes CEO13
- Jun 4, 2014New chief executive D. Alan Meeker becomes CEO14
- Jul 1, 1999Founded Fuse Medical, Inc. is founded2
Calendar
When it reported results
- Sep 27, 2023Reported quarterly or annual results30
- Aug 15, 2023Reported quarterly or annual results31
- Apr 18, 2023Reported quarterly or annual results33
- Nov 18, 2022Reported quarterly or annual results35
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
33 filings to the SEC since October 2021: 2 annual reports, 6 quarterly reports, 11 major events, 7 insider forms, 7 other. The latest 20:
- Sep 27, 202315-12G EDGAR
- Sep 27, 20238-K EDGAR
- Aug 15, 20238-K EDGAR
- Aug 14, 202310-Q EDGAR
- Jun 26, 20238-K EDGAR
- May 15, 202310-Q EDGAR
- May 10, 2023DEFA14A EDGAR
- May 10, 2023DEF 14A EDGAR
- May 10, 2023ARS EDGAR
- Apr 18, 20238-K EDGAR
- Apr 14, 202310-K EDGAR
- Apr 3, 2023NT 10-K EDGAR
- Dec 16, 20224 FORM 4 SUBMISSION EDGAR
- Dec 16, 20224 FORM 4 SUBMISSION EDGAR
- Dec 16, 20224 FORM 4 SUBMISSION EDGAR
- Nov 22, 20228-K EDGAR
- Nov 18, 20228-K EDGAR
- Nov 17, 20224 FORM 4 SUBMISSION EDGAR
- Nov 14, 202210-Q EDGAR
- Aug 11, 202210-Q EDGAR
The 33 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- PPP loans $361.4K
Figures by year
| Year | PPP loans | Total |
|---|---|---|
| 2020 | $361.4K | $361.4K |
PPP loans
Paycheck Protection Program loans of $150,000 and up, approved April 2020 to July 2021, from the SBA41. Matched to this company by name and state.
- Apr 10, 2020$361.4K PPP loan (first draw) from Zions Bank, A Division of41To FUSE MEDICAL, INC., Richardson TX; $365.4K forgiven May 20, 2021
SEC filer profile
How Fuse Medical, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARFuse Medical, Inc.1
- CIK0000319016
- Employer ID (EIN)59-12249131
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inDelaware1
- Fiscal year endsDecember 311
- Industry code (SIC)5047 Wholesale-Medical, Dental & Hospital Equipment & Supplies1
- Business address1565 North Central Expressway, Suite 220, Richardson, TX 750801
- Phone469-862-30301
- Shares outstanding73,895,794 as of Aug 10, 202311
- Public float$1.0M as of Jun 30, 20224
- On EDGAR sinceJul 13, 19951
- Filings401 in all: 8-K (73), 4 (49), 10-Q (46), 10QSB (40), 3 (20), 10-K (14), 4/A (14), UPLOAD (14)1
All 41 form types
10KSB (13), 8-K/A (12), SC 13D (12), CORRESP (9), NT 10-K (9), NT 10-Q (7), DEF 14A (6), DEFA14A (6), 10-K/A (4), 3/A (4), D (4), DEF 14C (4), SC 13D/A (4), 10KSB/A (3), 5 (3), CT ORDER (3), NTN 10Q (3), PRE 14A (3), PRE 14C (3), 10-Q/A (2), DEFR14C (2), S-8 (2), SC 13G/A (2), SC 14F1 (2), 10-KT (1), 10KSB40 (1), 10QSB/A (1), 15-12G (1), ARS (1), DEFA14C (1), NTN 10K (1), PRER14C (1), SC 13G (1)
- Latest filingsAnnual report (10-K) Apr 14, 2023
Quarterly report (10-Q) Aug 14, 2023
Proxy statement (DEF 14A) May 10, 2023
Latest 8-K (8-K) Sep 27, 2023
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARChris Pratt, Chief executive officer
- 14
- 15SEC EDGARMark W. Brooks, Chair
- 16SEC EDGARMark W. Brooks, President
- 17SEC EDGARRobert H. Donehew, President
- 18
- 19
- 20
- 21
- 22SEC EDGARWilliam E. McLaughlin Iii., Officer
- 23SEC EDGARMark W. Brooks, Officer
- 24SEC EDGARChris Pratt, Chief Medical Officer
- 25
- 26
- 27SEC EDGARRenato Bosita V. Jr., Board member
- 28SEC EDGARRicky Raj S. Kalra, Board member
- 29
- 30SEC EDGARResults of operations
- 31SEC EDGARResults of operations
- 32SEC EDGARShareholder vote
- 33SEC EDGARResults of operations
- 34SEC EDGARChange of auditor
- 35SEC EDGARResults of operations
- 36SEC EDGARShareholder vote
- 37SEC EDGARExecutive or director change
- 38SEC EDGARNew debt or obligation
- 39SEC EDGARExecutive or director change
- 40SEC EDGAREntered a material agreement
- 41
- 42